About the Authors

Liam P. Mullins

Contributed equally to this work with: Liam P. Mullins, Emily Mason

Roles Conceptualization, Visualization, Writing – original draft, Writing – review & editing

Affiliations Experimental Medicine Program, Department of Medicine, University of British Columbia, Vancouver, Canada, Vaccine Evaluation Center, BC Children’s Hospital Research Institute, Vancouver, Canada

Emily Mason

Contributed equally to this work with: Liam P. Mullins, Emily Mason

Roles Conceptualization, Writing – original draft, Writing – review & editing

Affiliations Experimental Medicine Program, Department of Medicine, University of British Columbia, Vancouver, Canada, Vaccine Evaluation Center, BC Children’s Hospital Research Institute, Vancouver, Canada

Kaitlin Winter

Roles Supervision, Visualization, Writing – original draft, Writing – review & editing

Affiliations Vaccine Evaluation Center, BC Children’s Hospital Research Institute, Vancouver, Canada, Department of Pediatrics, University of British Columbia, Vancouver, Canada

Manish Sadarangani

Roles Supervision, Visualization, Writing – review & editing

msadarangani@bcchr.ubc.ca

Affiliations Vaccine Evaluation Center, BC Children’s Hospital Research Institute, Vancouver, Canada, Department of Pediatrics, University of British Columbia, Vancouver, Canada

Competing Interests

MS has been an investigator on projects funded by GlaxoSmithKline, Merck, Moderna, Pfizer, Sanofi-Pasteur, Seqirus, Symvivo and VBI Vaccines. All funds have been paid to his institute, and he has not received any personal payments. KW is an inventor on patents (Canada and United States) for a vaccine against Clostridioides difficile held by Aviex Technologies LLC. LM and EM have declared no competing interests exist.